Welcome to Impact Factor, your weekly dose of commentary on a new study in medicine. I’m Dr. F. Perry Wilson, Yale School of Medicine. It was only three years ago that we called the pathogen we now refer to as coronavirus “nCOV-19.” It was, in many ways, more descriptive than what we have today. The … Read more
Dr. Borja De Miguel MADRID, ESP. “We must not forget that the main cause of mortality in patients with systemic autoimmune diseases is infections, ahead of the disease activity itself,” he commented to Medscape in Spanish Dr. Borja De Miguel Campo, specialist in internal medicine at the Autoimmune and Systemic Diseases Unit of the 12 … Read more
According to a Dutch prospective cohort study presented at the European Alliance of Associations for Rheumatology (EULAR) 2023 Annual Meeting, rheumatic disease is not considered a significant risk factor for long COVID. Although more patients with inflammatory rheumatic diseases (iRD) report symptoms resembling long COVID, the data suggest that many of these symptoms can be … Read more
A new study has found that less than 7% of patients newly diagnosed with cancer are tested for germline genetic mutations, and the rate is even lower among racial and ethnic minorities. Germline genetic testing can affect a patient’s cancer care, as it can indicate whether targeted therapies would be beneficial and can have implications … Read more